Yi Lin, MD, PhD
Yi Lin is a Hematologist and Chair at Cell Therapy Group, Division of Hematology, Mayo Clinic, Rochester, Minnesota. She completed her graduation and PhD from University of Minnesota and MD from Northwestern University Feinberg School of Medicine. Dr. Yi Lin completed Residency in Internal Medicine and a obtained Fellowship in Hematology and Medical Oncology from Mayo Clinic College of Medicine.
Dr. Yi Lin has special interests in cellular therapy, cancer vaccine, immunotherapy, myeloid cell biology, myeloma, dysproteinemia, amyloidosis and lymphoma.
Representative Publications:
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria
